Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test
NCT02432027
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
C-82 Topical Gel, Placebo
DRUG:
C-82 Topical Gel, 1%
DRUG:
Daivonex cream
DRUG:
Diprosis gel
Sponsor
Prism Pharma Co., Ltd.